Literature DB >> 28285783

Histopathological changes in morphea and their clinical correlates: Results from the Morphea in Adults and Children Cohort V.

Daniel Walker1, Joseph S Susa2, Sharif Currimbhoy2, Heidi Jacobe3.   

Abstract

BACKGROUND: Histopathological features in morphea (localized scleroderma) and their clinical correlates are poorly described.
OBJECTIVE: We sought to systematically describe histologic changes of morphea in a large, well-annotated cohort and determine the association between histopathology and clinical features.
METHODS: This was a cross-sectional study of 83 patients enrolled in the Morphea in Adults and Children cohort. The main outcome measure was the association of microanatomical location and degree of sclerosis and inflammation seen on histologic samples with patient-reported symptoms and physician-based measures of severity.
RESULTS: Pattern of sclerosis was associated with morphea subtype, the presence of patient-reported symptoms, and functional limitation. A bottom-heavy pattern of sclerosis was associated with pain and tightness (P = .0039 and .001, respectively). These symptoms were not associated with a top-heavy pattern. Severe inflammation may be associated with pain and functional limitation (P = .073 for both). LIMITATIONS: Small sample size limits ability to detect associations, particularly in subgroups.
CONCLUSIONS: Histopathological examination of morphea may assist in identifying patients who may require additional monitoring and treatment. Features such as patterns of sclerosis and severity of inflammation should be included in pathology reports to help aid in clinical management.
Copyright © 2016 American Academy of Dermatology, Inc. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  morphea; pain; pathology; sclerosis; severity; symptoms

Mesh:

Year:  2017        PMID: 28285783      PMCID: PMC5438266          DOI: 10.1016/j.jaad.2016.12.020

Source DB:  PubMed          Journal:  J Am Acad Dermatol        ISSN: 0190-9622            Impact factor:   11.527


  21 in total

1.  Dermatohistopathology of various types of scleroderma.

Authors:  H MONTGOMERY; P A O'LEARY; W E RAGSDALE
Journal:  AMA Arch Derm       Date:  1957-01

2.  Skin involvement in scleroderma--where histological and clinical scores meet.

Authors:  F Verrecchia; J Laboureau; O Verola; N Roos; R Porcher; P Bruneval; M Ertault; K Tiev; L Michel; A Mauviel; D Farge
Journal:  Rheumatology (Oxford)       Date:  2007-01-25       Impact factor: 7.580

3.  Juvenile localized scleroderma: clinical and epidemiological features in 750 children. An international study.

Authors:  F Zulian; B H Athreya; R Laxer; A M Nelson; S K Feitosa de Oliveira; M G Punaro; R Cuttica; G C Higgins; L W A Van Suijlekom-Smit; T L Moore; C Lindsley; J Garcia-Consuegra; M O Esteves Hilário; L Lepore; C A Silva; C Machado; S M Garay; Y Uziel; G Martini; I Foeldvari; A Peserico; P Woo; J Harper
Journal:  Rheumatology (Oxford)       Date:  2005-12-20       Impact factor: 7.580

4.  Histopathologic differentiation between localized and systemic scleroderma.

Authors:  J E Torres; J L Sánchez
Journal:  Am J Dermatopathol       Date:  1998-06       Impact factor: 1.533

5.  Histochemical differentiation of localized morphea-scleroderma and lichen sclerosus et atrophicus.

Authors:  H Rahbari
Journal:  J Cutan Pathol       Date:  1989-12       Impact factor: 1.587

Review 6.  Cytokine profiles in localized scleroderma and relationship to clinical features.

Authors:  Katherine Kurzinski; Kathryn S Torok
Journal:  Cytokine       Date:  2011-05-04       Impact factor: 3.861

7.  An evaluation of long-term outcomes in adults with pediatric-onset morphea.

Authors:  Stephanie Saxton-Daniels; Heidi T Jacobe
Journal:  Arch Dermatol       Date:  2010-09

8.  Myofibroblasts and hyalinized collagen as markers of skin disease in systemic sclerosis.

Authors:  Eugene Y Kissin; Peter A Merkel; Robert Lafyatis
Journal:  Arthritis Rheum       Date:  2006-11

9.  Skin thickness score in systemic sclerosis: an assessment of interobserver variability in 3 independent studies.

Authors:  P J Clements; P A Lachenbruch; J R Seibold; B Zee; V D Steen; P Brennan; A J Silman; N Allegar; J Varga; M Massa
Journal:  J Rheumatol       Date:  1993-11       Impact factor: 4.666

10.  The role of skin trauma in the distribution of morphea lesions: a cross-sectional survey of the Morphea in Adults and Children cohort IV.

Authors:  Daniel Grabell; Clifford Hsieh; Rachel Andrew; Kathryn Martires; Andrew Kim; Rebecca Vasquez; Heidi Jacobe
Journal:  J Am Acad Dermatol       Date:  2014-05-28       Impact factor: 11.527

View more
  10 in total

1.  Is it really post-irradiation morphea or oleoma of the breast?-A case report and literature review.

Authors:  Han Shin Lee; Eun Jung Jung; Jae Myung Kim; Ju Yeon Kim; In Kyeong Kim; Jae Ri Kim; Tae Han Kim; Jae Yool Jang; Jung Woo Woo; JinKwon Lee; Taejin Park; Sang Ho Jeong; Eun Cho; Hyo Jung An
Journal:  Gland Surg       Date:  2021-12

2.  Linear Scleroderma of the Head - Updates in management of Parry Romberg Syndrome and En coup de sabre: A rapid scoping review across subspecialties.

Authors:  Daniel H Glaser; Christina Schutt; Helena M VonVille; Kaila Schollaert-Fitch; Kathryn Torok
Journal:  Eur J Rheumatol       Date:  2020-02

Review 3.  Progressive Hemifacial Atrophy and Linear Scleroderma En Coup de Sabre: A Spectrum of the Same Disease?

Authors:  Irina Khamaganova
Journal:  Front Med (Lausanne)       Date:  2018-01-31

Review 4.  Update on Management of Morphea (Localized Scleroderma) in Children.

Authors:  Renu George; Anju George; T Sathish Kumar
Journal:  Indian Dermatol Online J       Date:  2020-03-09

Review 5.  Immunopathogenesis of Pediatric Localized Scleroderma.

Authors:  Kathryn S Torok; Suzanne C Li; Heidi M Jacobe; Sarah F Taber; Anne M Stevens; Francesco Zulian; Theresa T Lu
Journal:  Front Immunol       Date:  2019-04-30       Impact factor: 7.561

6.  Superficial Morphea: Clinicopathological Characteristics and a Novel Therapeutic Outcome to Excimer Light Therapy.

Authors:  Al-Sadat Mosbeh; Soha Aboeldahab; Mohamed El-Khalawany
Journal:  Dermatol Res Pract       Date:  2019-09-19

Review 7.  Morphea: progress to date and the road ahead.

Authors:  Laila Abbas; Adrienne Joseph; Elaine Kunzler; Heidi T Jacobe
Journal:  Ann Transl Med       Date:  2021-03

8.  Autoantigen microarrays reveal myelin basic protein autoantibodies in morphea.

Authors:  Jane L Zhu; Ricardo T Paniagua; Henry W Chen; Stephanie Florez-Pollack; Elaine Kunzler; Noelle Teske; Yevgeniya Byekova Rainwater; Quan-Zhen Li; Gregory A Hosler; Wenhao Li; Denise M O Ramirez; Nancy L Monson; Heidi T Jacobe
Journal:  J Transl Med       Date:  2022-01-24       Impact factor: 5.531

9.  Application of an iPSC-Derived Organoid Model for Localized Scleroderma Therapy.

Authors:  Jie Ma; Wei Li; Ruiyuan Cao; Dunqin Gao; Qiyu Zhang; Xiao Li; Biyou Li; Luye Lv; Mansheng Li; Junyi Jiang; Yujie Wang; Jun Li; Zhihong Wu; Yunping Zhu; Wu Zhong; Shuyang Zhang; Ling Leng
Journal:  Adv Sci (Weinh)       Date:  2022-03-22       Impact factor: 17.521

10.  A Case of Extensive Debilitating Generalized Morphea.

Authors:  Amit Sapra; Rebecca Dix; Priyanka Bhandari; Asiya Mohammed; Eukesh Ranjit
Journal:  Cureus       Date:  2020-05-14
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.